VBIVUnknown
VBI Vaccines Inc/BC Insider Trading Activity
Every SEC Form 4 insider transaction reported for VBI Vaccines Inc/BC (VBIV), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are VBIV insiders buying or selling?
VBI Vaccines Inc/BC insiders reported 25 open-market buys ($49.8M) and 4 sells ($18.6M) across 29 Form 4 filings — a net buying position of $31.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 18, 2023)
Total Form 4 filings
29
SEC EDGAR
Insider filers
7
Insider buys (25)
$49.8M
Insider sells (4)
$18.6M
Insider sentiment
Net buyingNet insider flow of $31.2M in net buying.
Recent VBIV insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 18, 2023 | Steven Gillis | Director | Purchase | 609.1K | $1.65 | $1.0M |
| Apr 6, 2023 | Joseph Edelman | 10% Owner | Sale | 10.9M | $0.14 | $1.5M |
| Dec 6, 2021 | Nell Beattie | Chief Business Officer | Purchase | 8.2K | $2.45 | $20.1K |
| Dec 3, 2021 | Joseph Edelman | 10% Owner | Sale | 2.7M | $3.31 | $9.0M |
| Jun 30, 2021 | Joseph Edelman | 10% Owner | Sale | 646.3K | $3.80 | $2.5M |
| Jun 11, 2021 | Joseph Edelman | 10% Owner | Sale | 1.4M | $4.00 | $5.7M |
| Apr 28, 2020 | Joseph Edelman | 10% Owner | Purchase | 9.1M | $1.10 | $10.0M |
| Oct 7, 2019 | Francisco Diaz-Mitoma | Chief Medical Officer | Purchase | 54.5K | $0.50 | $27.3K |
| Oct 1, 2019 | Christopher Mcnulty | CFO and Head of BD | Purchase | 12.0K | $0.47 | $5.7K |
| Oct 1, 2019 | Nell Beattie | Chief Business Officer | Purchase | 10.0K | $0.48 | $4.8K |
| Sep 30, 2019 | Jeff Baxter | CEO, President | Purchase | 150.0K | $0.50 | $75.5K |
| Sep 24, 2019 | Joseph Edelman | 10% Owner | Purchase | 20.0M | $0.50 | $10.0M |
| Sep 24, 2019 | Steven Gillis | Director | Purchase | 10.0M | $0.50 | $5.0M |
| Jul 1, 2019 | Francisco Diaz-Mitoma | Chief Medical Officer | Purchase | 8.0K | $1.07 | $8.6K |
| Jun 20, 2019 | Francisco Diaz-Mitoma | Chief Medical Officer | Purchase | 52.0K | $0.87 | $45.2K |
| Jun 20, 2019 | Joseph Edelman | 10% Owner | Purchase | 1.0M | $0.65 | $650.0K |
| Jun 19, 2019 | Nell Beattie | Chief Business Officer | Purchase | 8.0K | $0.74 | $5.9K |
| Jun 19, 2019 | Jeff Baxter | CEO, President | Purchase | 144.0K | $0.73 | $105.3K |
| Jun 18, 2019 | Joseph Edelman | 10% Owner | Purchase | 1.0M | $0.62 | $618.0K |
| Dec 18, 2018 | Kariv Tomer | Director | Purchase | 1.4M | $1.40 | $2.0M |
| Dec 17, 2018 | Joseph Edelman | 10% Owner | Purchase | 14.3M | $1.40 | $20.0M |
| Aug 8, 2018 | Jeff Baxter | CEO, President | Purchase | 8.1K | $1.93 | $15.6K |
| Aug 6, 2018 | Francisco Diaz-Mitoma | Chief Medical Officer | Purchase | 9.0K | $2.13 | $19.2K |
| Aug 6, 2018 | Jeff Baxter | CEO, President | Purchase | 13.5K | $2.01 | $27.1K |
| Aug 3, 2018 | Nell Beattie | Chief Business Officer | Purchase | 2.0K | $2.01 | $4.0K |
Showing the 25 most recent of 29 Form 4 filings for VBI Vaccines Inc/BC.
Most active VBIV insiders
- Joseph Edelman9 filings
- Jeff Baxter7 filings
- Francisco Diaz-Mitoma5 filings
- Nell Beattie4 filings
- Steven Gillis2 filings
Ask anything about VBIV insider activity
Use Trabud's AI agent to query VBI Vaccines Inc/BC's Form 4 history in plain English — "Show me VBIV CEO purchases this year" or compare it against any other ticker.
Open the AI agentVBIV insider trading FAQ
Are VBI Vaccines Inc/BC insiders buying or selling?
Across 29 SEC Form 4 filings, VBI Vaccines Inc/BC (VBIV) insiders reported 25 open-market purchases totaling $49.8M and 4 sales totaling $18.6M. That is a net buying position of $31.2M.
How many insiders trade VBIV stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for VBI Vaccines Inc/BC. The most recent filing was accepted on Jul 18, 2023.
Where does Trabud get VBIV insider trading data?
All VBIV insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.